Clinical efficacy of tofacitinib in active ankylosing spondylitis and dynamic changes in gut microbiota: an exploratory descriptive four-case series with 16S rRNA sequencing analysis. [PDF]
Front ImmunolWang L, Xie W, Li J, Chen J, Huang Y.
europepmc +1 more source
Tofacitinib in rheumatoid arthritis: a German real-world study with focus on treatment changes, effectiveness and patient-reported outcomes (ESCALATE-RA). [PDF]
BMJ OpenKrueger K +10 more
europepmc +1 more source
Lessons from extended induction and practical evidence for improving tofacitinib therapy in ulcerative colitis. [PDF]
World J GastroenterolFouad Y, Aboelela AS.
europepmc +1 more source
Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review. [PDF]
Front ImmunolWan Z, Wang Y, Yang D.
europepmc +1 more source
JAK inhibitor tofacitinib alleviates secretory dysfunction and Th17/Treg imbalance in a Sjögren's disease murine model. [PDF]
Ann MedLin Y +8 more
europepmc +1 more source
A Comparative Study of Oral Tofacitinib and Oral Methotrexate in the Treatment of Patients With Moderate to Severe Chronic Plaque Psoriasis. [PDF]
CureusUnnikrishnan P +5 more
europepmc +1 more source
Authors' Response to Comment on published article "A Real-World Study of Tofacitinib in Indian Patients with Refractory Moderate-to-Severe Atopic Dermatitis, its Economic Considerations and Immunological Rationale". [PDF]
Indian Dermatol Online JSardana K +4 more
europepmc +1 more source
Related searches:
Reimbursement reviews of drugs later in the life cycle include a comprehensive assessment of clinical value, unmet clinical need, distinct social and ethical considerations, economic considerations, and impacts on the health systems. The assessments inform nonbinding recommendations that help guide the reimbursement decisions of Canada’s federal ...
+16 more sources